血液分離設備市場規模、佔有率和成長分析：按產品類型、治療類型、技術、最終用戶、應用、移動性和地區分類－2026-2033年產業預測

2024 年全球血液分離設備市場價值為 48.7 億美元，預計到 2025 年將成長至 52.8 億美元，到 2033 年將成長至 100.7 億美元，在預測期（2026-2033 年）內複合年成長率為 8.4%。

全球血液分離設備市場涵蓋用於治療和診斷目的的血液成分分離設備，例如血漿置換系統和白血球分離設備。這個市場的主要促進因素是自體免疫疾病和慢性腎臟病盛行率的上升，以及對血漿衍生療法需求的不斷成長。生技藥品和血漿製品的快速普及，也促使醫院和專科診所對現代化基礎設施的需求日益增加。此外，在保險報銷機制的支持下，當日治療的門診血液分離服務不斷擴展，這也進一步推動了市場需求。物聯網系統和人工智慧分析等創新技術透過即時監控和流程最佳化，提高了效率和安全性。因此，這些進步簡化了工作流程，減輕了操作人員的疲勞，提高了治療的可靠性，並加速了血液分離技術在醫療機構中的廣泛應用。

全球血液分離設備市場按產品類型、操作類型、技術、最終用戶、應用、移動性和地區進行細分。依產品類型分類，可分為血漿分離設備、血小板分離設備、白血球分離設備及其他設備。依操作類型分類，可分為治療性血液分離及捐贈者血液分離。依技術分類，可分為離心系統和薄膜過濾系統。依最終用戶分類，可分為醫院、採血中心、專科診所和其他機構。按應用分類，可分為血液學、神經病學、腎臟病學和其他領域。依移動性分類，可分為固定式系統和可攜式系統。依地區分類，可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球血液分離設備市場的成長要素

隨著臨床醫生在治療複雜的血液和免疫系統疾病方面越來越依賴血液分離術，全球血液分離設備市場正經歷顯著成長。這種應用的增加促使醫院加快採購流程，也促使製造商拓展產品線。血液分離術在清除有害物質和提取有益細胞成分方面的有效性持續受到臨床關注，推動了研發和功能改進方面的投資。因此，醫療機構優先採用先進設備，以改善患者預後並最佳化營運效率。這一趨勢正在推動成熟市場和新興市場的成長，促進設備供應商和學術機構之間的合作，並最終加速該領域的創新。

全球血液分離設備市場的限制因素

全球血液分離設備市場面臨嚴峻挑戰，因為購買血液分離設備需要大量的初始投資。除了設備成本外，耗材、安裝服務和員工培訓等費用也進一步增加了採購的複雜性。預算緊張的醫療機構必須仔細評估投資報酬率，並且通常優先考慮滿足眼前的臨床需求，而不是資本密集解決方案。這些財務壓力會延長採購週期，尤其對於小規模的醫療機構和依賴公共資金的機構而言更是如此。因此，市場滲透率仍然有限，即使臨床效益顯而易見，其普及率也可能停滯不前。這導致許多機構選擇租賃協議或推遲設備升級，最終阻礙了短期成長。

全球血液分離設備市場趨勢

全球血液分離設備市場正呈現與個人化醫療顯著融合的趨勢，血液分離術擴大與生物目標療法相結合。這種雙管齊下的方法不僅可以即時清除病原細胞，還能同時輸注針對患者最佳化的藥物，從而提高治療效果並促進患者更快康復。隨著醫療保健系統優先考慮以價值為導向的醫療服務，醫療機構正轉向能夠簡化血液採集、處理和輸注流程的整合平台。此外，對可快速重構的模組化設備的需求，以應對複雜疾病，也為市場持續成長奠定了基礎，而臨床創新和個人化醫療正是推動這一成長的動力。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球血液分離設備市場規模：依產品類型分類

• 等離子分離器
• 血小板分離裝置
• 白血球分離裝置
• 其他

全球血液分離設備市場規模：依手術類型分類

• 治療性血液分離術
• 供體血漿分離術

全球血液分離設備市場規模：依技術分類

• 離心分離系統
• 薄膜過濾系統

全球血液分離設備市場規模：依最終用戶分類

• 醫院
• 採血中心
• 專科診所
• 其他

全球血液分離設備市場規模：依應用領域分類

• 血液學
• 神經病學
• 腎臟病學
• 其他

全球血液分離設備市場規模：依移動性分類

• 靜止系統
• 可攜式系統

全球血液分離設備市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Terumo Blood and Cell Technologies
• Fresenius Kabi AG
• Haemonetics Corporation
• B. Braun SE
• Nikkiso Co., Ltd.
• Asahi Kasei Medical Co., Ltd.
• Kaneka Corporation
• Miltenyi Biotec BV & Co. KG
• Macopharma SA
• Cerus Corporation
• Medica SpA
• Hemocare Corporation
• Infomed SA
• Sichuan Nigale Biomedical Co., Ltd.
• HemaCare Corporation
• Braile Biomedica
• Fresenius Medical Care AG
• Baxter International Inc.
• CytoSorbents Corporation
• Kawasumi Laboratories, Inc.

結論與建議

Global Apheresis Equipment Market size was valued at USD 4.87 Billion in 2024 and is poised to grow from USD 5.28 Billion in 2025 to USD 10.07 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global apheresis equipment market encompasses devices that isolate blood components for therapeutic and diagnostic applications, including plasma-exchange systems and leukapheresis machines. This market is driven by the rising prevalence of autoimmune disorders and chronic kidney disease, alongside an increasing demand for plasma-derived therapies. The urgency for hospitals and specialty clinics to modernize their infrastructure is fueled by accelerated biologics and plasma products. Additionally, the growth of outpatient apheresis services, supported by insurer reimbursements for same-day treatments, enhances market demand. Innovations such as IoT-enabled systems and AI-driven analytics improve efficiency and safety by providing real-time monitoring and optimizing processes. Consequently, these advancements facilitate smoother workflows, reduce operator fatigue, and enhance treatment reliability, encouraging wider adoption within healthcare settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Apheresis Equipment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Apheresis Equipment Market Segments Analysis

The global apheresis equipment market is segmented by product type, procedure type, technology, end user, application, mobility and region. Based on product type, the market is segmented into Plasmapheresis Equipment, Platelet Apheresis Equipment, Leukapheresis Equipment and Others. Based on procedure type, the market is segmented into Therapeutic Apheresis and Donor Apheresis. Based on technology, the market is segmented into Centrifugation-Based Systems and Membrane Filtration Systems. Based on end user, the market is segmented into Hospitals, Blood Collection Centers, Specialty Clinics and Others. Based on application, the market is segmented into Hematology, Neurology, Nephrology and Others. Based on mobility, the market is segmented into Stationary Systems and Portable Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Apheresis Equipment Market

The global apheresis equipment market is experiencing significant growth as clinicians increasingly rely on apheresis for complex hematologic and immunologic conditions. This rise in utilization prompts hospitals to expedite their procurement processes, encouraging manufacturers to expand their product offerings. The effectiveness of apheresis in removing harmful substances and collecting beneficial cellular materials keeps clinical interest high, driving investments in research, development, and enhancements. Consequently, healthcare organizations prioritize advanced devices to improve patient outcomes and streamline workflow efficiency. This dynamic fosters growth across both established and emerging markets, while also facilitating partnerships between equipment suppliers and academic institutions, thereby accelerating innovation in the field.

Restraints in the Global Apheresis Equipment Market

The Global Apheresis Equipment market faces significant challenges due to the substantial initial investment required for purchasing apheresis devices. Beyond the cost of the machines, additional expenses such as consumables, installation services, and staff training further complicate procurement. Health systems operating under strict budget constraints must carefully evaluate the return on investment, often prioritizing immediate clinical needs over capital-intensive solutions. This financial pressure can extend procurement timelines, particularly in smaller institutions or those reliant on public funding. Consequently, market penetration remains limited, and although the clinical benefits are evident, adoption may falter, leading many organizations to opt for leasing arrangements or delay upgrades, ultimately hindering short-term growth.

Market Trends of the Global Apheresis Equipment Market

The Global Apheresis Equipment market is experiencing a notable trend towards personalized therapeutic integration, where apheresis is increasingly combined with targeted biologic therapies. This dual approach not only allows for the real-time removal of pathogenic cells but also facilitates the simultaneous delivery of customized agents, enhancing treatment efficacy and promoting quicker patient recovery. As healthcare systems prioritize value-based care, providers are shifting towards integrated platforms that streamline the workflow of collection, processing, and infusion. Furthermore, the demand for modular equipment that can be rapidly reconfigured to cater to complex disease treatments underscores a market poised for sustained growth, driven by clinical innovation and tailored patient care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Apheresis Equipment Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Plasmapheresis Equipment
• Platelet Apheresis Equipment
• Leukapheresis Equipment
• Others

Global Apheresis Equipment Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Therapeutic Apheresis
• Donor Apheresis

Global Apheresis Equipment Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Centrifugation-Based Systems
• Membrane Filtration Systems

Global Apheresis Equipment Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Blood Collection Centers
• Specialty Clinics
• Others

Global Apheresis Equipment Market Size by Application & CAGR (2026-2033)

• Market Overview
• Hematology
• Neurology
• Nephrology
• Others

Global Apheresis Equipment Market Size by Mobility & CAGR (2026-2033)

• Market Overview
• Stationary Systems
• Portable Systems

Global Apheresis Equipment Market Size & CAGR (2026-2033)

• North America (Product Type, Procedure Type, Technology, End User, Application, Mobility)
  • US
  • Canada
• Europe (Product Type, Procedure Type, Technology, End User, Application, Mobility)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure Type, Technology, End User, Application, Mobility)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure Type, Technology, End User, Application, Mobility)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure Type, Technology, End User, Application, Mobility)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Terumo Blood and Cell Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec B.V. & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hemocare Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infomed SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sichuan Nigale Biomedical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HemaCare Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CytoSorbents Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations